CareDx, Inc. (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
26.18
+2.70 (11.50%)
At close: Jun 18, 2026, 4:00 PM EDT
26.16
-0.02 (-0.08%)
After-hours: Jun 18, 2026, 7:33 PM EDT

CareDx Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, CareDx stock has a consensus rating of "Buy" and an average price target of $25.8. The average 1-year stock price forecast is 1.45% lower than the current stock price, while the lowest is $21 (-19.79%) and the highest is $28 (+6.95%).

Price Target: $25.8 (-1.45%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$21$25.8$26$28
Change-19.79%-1.45%-0.69%+6.95%
* Price targets were last updated on Apr 29, 2026.

Analyst Ratings

The average analyst rating for CareDx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy333333
Buy000000
Hold555443
Sell000000
Strong Sell000000
Total888776

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Hold
Maintains
n/a
HoldMaintainsn/an/aJun 17, 2026
William Blair
William Blair
Hold
Reiterates
n/a
HoldReiteratesn/an/aMay 27, 2026
H.C. Wainwright
H.C. Wainwright
Hold
Reiterates
n/a
HoldReiteratesn/an/aApr 30, 2026
Unknown Analyst
Stephens
No rating
Stephens
Buy
Maintains
$28
BuyMaintains$28+6.95%Apr 29, 2026
BTIG
BTIG
Buy
Reiterates
$26$28
BuyReiterates$26$28+6.95%Apr 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
456.28M
from 379.81M
Increased by 20.14%
Revenue Next Year
476.18M
from 456.28M
Increased by 4.36%
EPS This Year
0.93
from 0.58
Increased by 61.03%
EPS Next Year
1.13
from 0.93
Increased by 21.41%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
296.40M321.79M280.32M333.79M379.81M456.28M
Revenue Growth
54.22%8.57%-12.89%19.07%13.79%20.14%
Gross Profit
199.01M209.58M178.26M224.09M256.57M320.31M
Gross Margin
67.14%65.13%63.59%67.14%67.55%70.20%
Operating Income
-29.73M-77.23M-107.06M-55.54M-22.81M-7.56M
Net Income
-30.66M-76.61M-190.28M52.55M-21.35M407.08K
EPS
----0.580.93
EPS Growth
----5.45%61.03%
Forward PE
180.12--51.3821.2528.03
Free Cash Flow
-21.19M-18.00M10.97M43.22M45.75M52.00M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High457.1M
Avg456.3M
Low454.6M

Revenue Growth

Revenue Growth202620272028
High
20.4%
Avg
20.1%
Low
19.7%

EPS Forecast

EPS202620272028
High1.02
Avg0.93
Low0.88

EPS Growth

EPS Growth202620272028
High
75.9%
Avg
61.0%
Low
51.7%